Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yo Muraki, Takako Naito, Kimio Tohyama, Sachio Shibata, Kanako Kuniyeda, Yasunori Nio, Masatoshi Hazama & Takanori Matsuo. (2019) Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension. Bioscience, Biotechnology, and Biochemistry 83:6, pages 1000-1010.
Read now
Read now
Michael J Palmer. (2009) Leads for the treatment of pulmonary hypertension. Expert Opinion on Therapeutic Patents 19:5, pages 575-592.
Read now
Read now
Articles from other publishers (4)
Ruiying Wang, Min Wang, Shuaibing He, Guibo Sun & Xiaobo Sun. (2020) Targeting Calcium Homeostasis in Myocardial Ischemia/Reperfusion Injury: An Overview of Regulatory Mechanisms and Therapeutic Reagents. Frontiers in Pharmacology 11.
Crossref
Crossref
Yo Muraki, Midori Yamasaki, Hirohisa Takeuchi, Kimio Tohyama, Noriyasu Sano & Takanori Matsuo. (2018) Fluorescent Imaging Analysis for Distribution of Fluorescent Dye Labeled- or Encapsulated-Liposome in Monocrotaline-Induced Pulmonary Hypertension Model Rat. Chemical and Pharmaceutical Bulletin 66:3, pages 270-276.
Crossref
Crossref
Michael J. Palmer. 2014. Orphan Drugs and Rare Diseases. Orphan Drugs and Rare Diseases
369
397
.
Jean M. Elwing, Gail H. Deutsch, William C. Nichols & Timothy D. Le Cras. 2010. Molecular Basis of Pulmonary Disease. Molecular Basis of Pulmonary Disease
39
84
.